CG Oncology, Inc. (CGON)
NMS – Real Time Price. Currency in USD
78.55
+1.52 (1.97%)
Market open: Aug 12, 2026, 11:21 AM EDT
77.00
-0.03 (-0.04%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
78.55
+1.52 (1.97%)
Market open: Aug 12, 2026, 11:21 AM EDT
77.00
-0.03 (-0.04%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $19.6M significantly exceed its total debt $8.8M, ensuring strong financial flexibility
Total current assets $1.0B exceed Total current liabilities $47.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$46.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 22.22 | 6.05 | 10 | |
| Quick ratio | 22.20 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 191K | 204K | 1M | 4M | 6M |
| Gross Profit | 176K | 187K | 1M | -652K | -6M |
| Operating Income | -35M | -55M | -115M | -191M | -253M |
| Net Income | -35M | -49M | -88M | -161M | -224M |
| EBITDA | -35M | -55M | -115M | -189M | -250M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -70.51 | -41.68 | 1.0 |
| Next quarter | -77.57 | -52.12 | 1.0 |
| Current year | 4.29 | -55.29 | 2.5 |
| Next year | 1990.62 | 7.49 | 7.5 |
| Weighted average score | 3.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.83 | -31.31 | -26.75 | 18.11 | 4.0 |
| Y/Y | 999 | -90.83 | -66.66 | -67.59 | 3.3 |
| 3y average | 239.95 | -67.02 | -36.41 | -64.59 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |